Lilach Bonstein
Lilach Bonstein has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Eldad J. Dann
Blood Bank and Platelet Immunology Laboratories Haifa Israel
2 shared publicationsNuhad Haddad
Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel
2 shared publicationsAlla Badian
Blood Bank and Apheresis Unit, Rambam Health Care Campus, Haifa, Israel
1 shared publicationAvraham Lorber
Pediatric Cardiology, Rambam Health Care Campus, Haifa, Israel
1 shared publication- Chen Ben David
Department of Obstetrics and Gynecology Rambam Health Care Campus Haifa Israel
1 shared publication Diana Gaitini
Department of Radiology, Rambam Health Care Campus, Haifa, Israel
1 shared publication
Latest Publications
- Open Access
- 24 July 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (10) , 1111-1115
Routine maternal ABO/Rhesus D blood typing can alert of massive foetomaternal haemorrhage
Background and Objectives: Spontaneous massive foetomaternal haemorrhage (SM‐FMH) is a rare yet critical condition that poses substantial risk to foetal health and survival. Existing data indicate that many cases may be undiagnosed. The current study aimed to investigate and validate the utility of identifying mixed field red blood cell (RBC) agglutination during maternal blood typing as a diagnostic aid for SM‐FMH.Materials and Methods: Retrospective analysis of medical records from neonates born at our tertiary, university‐affiliated medical centre between 2016 and 2023 was performed. Diagnosis of SM‐FMH was based on neonates born with severe anaemia (haematocrit [HCT] <15%) within the first 24 h post‐delivery with positive maternal Kleihauer–Betke (KB) test. Maternal ABO/Rhesus D (RhD) blood typing results were scrutinized with the primary objective of assessing the ability to identify dual RBC populations in cases clinically diagnosed with SM‐FMH.Results: Among 29,192 neonates studied, a mere 0.02% (5 cases) exhibited severe SM‐FMH. Notably, a mixed field RBC agglutination was discerned in 80% (4/5) of these cases.Conclusion: This study underscores the significance of detecting mixed field RBC agglutination during antepartum maternal ABO/RhD blood typing as a potential indicator for SM‐FMH. Increased awareness among blood bank technology specialists and obstetricians regarding these laboratory findings could prove instrumental in saving foetal lives.
- 24 July 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (10) , 1111-1115
Open AccessRoutine maternal ABO/Rhesus D blood typing can alert of massive foetomaternal haemorrhage
Background and Objectives: Spontaneous massive foetomaternal haemorrhage (SM‐FMH) is a rare yet critical condition that poses substantial risk to foetal health and survival. Existing data indicate that many cases may be undiagnosed. The current study aimed to investigate and validate the utility of identifying mixed field red blood cell (RBC) agglutination during maternal blood typing as a diagnostic aid for SM‐FMH.Materials and Methods: Retrospective analysis of medical records from neonates born at our tertiary, university‐affiliated medical centre between 2016 and 2023 was performed. Diagnosis of SM‐FMH was based on neonates born with severe anaemia (haematocrit [HCT] <15%) within the first 24 h post‐delivery with positive maternal Kleihauer–Betke (KB) test. Maternal ABO/Rhesus D (RhD) blood typing results were scrutinized with the primary objective of assessing the ability to identify dual RBC populations in cases clinically diagnosed with SM‐FMH.Results: Among 29,192 neonates studied, a mere 0.02% (5 cases) exhibited severe SM‐FMH. Notably, a mixed field RBC agglutination was discerned in 80% (4/5) of these cases.Conclusion: This study underscores the significance of detecting mixed field RBC agglutination during antepartum maternal ABO/RhD blood typing as a potential indicator for SM‐FMH. Increased awareness among blood bank technology specialists and obstetricians regarding these laboratory findings could prove instrumental in saving foetal lives.
- 24 March 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (6) , e728-e732
Neonatal Thrombocytopenia: Differing Characteristics of NAIT Versus Non-NAIT
While neonatal alloimmune thrombocytopenia (NAIT) is the most common cause of severe neonatal thrombocytopenia good clinical predictors are lacking. We analyzed cases of neonatal thrombocytopenia in Schneider Children’s Medical Center of Israel to pinpoint qualifiers of NAIT (NAIT+) in comparison to non-NAIT (NAIT−) thrombocytopenia. Patient and maternal data were retrospectively collected on all thrombocytopenic newborns undergoing a workup for NAIT in our tertiary center between 2001 and 2016. Among 26 thrombocytopenic neonates, the mean nadir in NAIT+ patients (25×109/L) was significantly lower than NAIT− patients (64×109/L) (PP=0.015). NAIT+ patients also required more therapeutic modalities than infants with NAIT− thrombocytopenia. Human platelet antigen (HPA)-1a and HPA-5b alloantibodies most frequently caused NAIT. In summary, thrombocytopenia in NAIT+ was significantly more severe compared with NAIT− and more likely to require treatment. In addition, despite the varied ethnic population in Israel, the HPA alloantibodies found in our population were most similar to those common in Western countries. In the absence of rigorous prenatal screening options, we suggest platelet counts below 40 to 50×109/L in a healthy newborn be considered most suggestive for NAIT and warrant urgent NAIT-specific analysis.
- 24 March 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (6) , e728-e732
Neonatal Thrombocytopenia: Differing Characteristics of NAIT Versus Non-NAIT
While neonatal alloimmune thrombocytopenia (NAIT) is the most common cause of severe neonatal thrombocytopenia good clinical predictors are lacking. We analyzed cases of neonatal thrombocytopenia in Schneider Children’s Medical Center of Israel to pinpoint qualifiers of NAIT (NAIT+) in comparison to non-NAIT (NAIT−) thrombocytopenia. Patient and maternal data were retrospectively collected on all thrombocytopenic newborns undergoing a workup for NAIT in our tertiary center between 2001 and 2016. Among 26 thrombocytopenic neonates, the mean nadir in NAIT+ patients (25×109/L) was significantly lower than NAIT− patients (64×109/L) (PP=0.015). NAIT+ patients also required more therapeutic modalities than infants with NAIT− thrombocytopenia. Human platelet antigen (HPA)-1a and HPA-5b alloantibodies most frequently caused NAIT. In summary, thrombocytopenia in NAIT+ was significantly more severe compared with NAIT− and more likely to require treatment. In addition, despite the varied ethnic population in Israel, the HPA alloantibodies found in our population were most similar to those common in Western countries. In the absence of rigorous prenatal screening options, we suggest platelet counts below 40 to 50×109/L in a healthy newborn be considered most suggestive for NAIT and warrant urgent NAIT-specific analysis.
- 1 March 2017
- Published by Elsevier in Thrombosis Research
- Vol. 151, S100-S102
Taking a wider view on fetal/neonatal alloimmune thrombocytopenia
- 1 March 2017
- Published by Elsevier in Thrombosis Research
- Vol. 151, S100-S102
Taking a wider view on fetal/neonatal alloimmune thrombocytopenia
- 15 August 2012
- Published by Wiley in Transfusion
- Vol. 53 (5) , 1019-1023
Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation
- 15 August 2012
- Published by Wiley in Transfusion
- Vol. 53 (5) , 1019-1023
Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation